Skip to main content
Log in

Loss of blood group antigen a in non-small cell lung cancer

  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background: Many human tumor cells display alterations in blood group antigen expression, and the loss of antigen A expression by non-small cell lung cancer (NSCLC) in blood group A patients has recently been associated with decreased survival.

Methods: To confirm this finding, we performed a retrospective study of 62 NSCLC patients undergoing potentially curative resection between August 1987 and December 1991 who were blood group A and had paraffin-embedded primary lung cancer tissue suitable for immunohistological analysis of antigen A expression. Twenty-seven patients expressed antigen A in their tumors, whereas 35 had loss of antigen expression. Disease-free survival (DFS) curves were calculated for stage I (n=26) and IIIA (n=25) patients.

Results: The two groups of patients with or without antigen A expression did not have significantly different DFS. A proportional hazards regression analysis identified no significant difference in the DFS of stage I patients with or without antigen A, but stage IIIA patients who had preservation of antigen A had significantly shorter DFS than did those who lost antigen A (p=0.0002).

Conclusions: The loss of expression of antigen A by primary tumor cells was not a significant adverse prognostic factor in DFS in our series, and we would recommend further studies to define clearly the clinical importance of antigen A expression in pulmonary carcinoma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Davidsohn I, Kovarik S, Lee CL. A, B, and O substances in gastrointestinal carcinoma.Arch Pathol 1966;81:381–90.

    CAS  PubMed  Google Scholar 

  2. Kovarik S, Davidsohn I, Stejskal R. ABO antigens in cancer: detection with the mixed cell agglutination reaction.Arch Pathol 1968;86:12–21.

    CAS  PubMed  Google Scholar 

  3. Davidsohn I, Kovarik S, Ni LY. Isoantigens A, B, and H in benign and malignant lesions of the cervix.Arch Pathol 1969;87:306–14.

    CAS  PubMed  Google Scholar 

  4. Davidsohn I, Ni LY. Loss of isoantigens A, B, and I in carcinoma of the lung.Am J Pathol 1969;57:307–34.

    CAS  PubMed  Google Scholar 

  5. Hirohashi S, Ino Y, Kodama T, Shimosato Y. Distribution of blood group antigens A, B, H, and I (Ma) in mucus-producing adenocarcinoma of human lung.J Natl Cancer Inst 1984;72:1299–305.

    CAS  PubMed  Google Scholar 

  6. Hakomori S. Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens.Adv Cancer Res 1989;52:257–331.

    CAS  PubMed  Google Scholar 

  7. Davidsohn I, Norris HJ, Stejskal R, Lill P. Metastatic squamous cell carcinoma of the cervix: the role of immunology in its pathogenesis.Arch Pathol 1973;95:132–4.

    CAS  PubMed  Google Scholar 

  8. Juhl BR, Hartzen SH, Hainau B. A, B, H antigen expression in transitional cell carcinomas of the urinary bladder.Cancer 1986;57:1768–75.

    CAS  PubMed  Google Scholar 

  9. Lee JS, Ro JY, Sahin AA, Hong WK, Brown BW, Mountain CF, Hittelman WN. Expression of blood-group antigen A—a favorable prognostic factor in non-small-cell lung cancer.N Engl J Med 1991;324:1084–90.

    CAS  PubMed  Google Scholar 

  10. Miyake M, Taki T, Hitomi S, Hakomori S-I. Correlation of expression of H/Le4/Leb antigens with survival in patients with carcinoma of the lung.N Engl J Med 1992;327:14–8.

    CAS  PubMed  Google Scholar 

  11. Kaplan EL, Meier P. Nonparametric estimation for incomplete observations.J Am Stat Assoc 1958;53:457–81.

    Google Scholar 

  12. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration.Cancer Chem Rep 1966;50:163–70.

    CAS  Google Scholar 

  13. Breslow N. A generalized Kruskal-Wallis test for comparing K samples subject to unequal patterns of censorship.Biometrika 1970;57:579–94.

    Google Scholar 

  14. Cox DR. Regression models and life tables.J R Stat Soc 1972;34:187–220.

    Google Scholar 

  15. Dixon WJ.BMDP statistical software. Berkeley, CA: University of California Press, 1985.

    Google Scholar 

  16. Mountain CF. Prognostic implications of the international staging system for lung cancer.Semin Oncol 1988;15:236–45.

    CAS  PubMed  Google Scholar 

  17. Gail MH, Eagan RT, Feld R, Ginsberg R, Goodell B, Hill L, Holmes EC, et al. Prognostic factors in patients with resected stage I non-small cell lung cancer: a report from the Lung Cancer Study Group.Cancer 1984;54:1802–13.

    CAS  PubMed  Google Scholar 

  18. Naruke T, Goya T, Tsuchiya T, Suemasu K. Prognosis and survival in resected lung carcinoma based on the new international staging system.J Thorac Cardiovasc Surg 1988;96:440–7.

    CAS  PubMed  Google Scholar 

  19. Miyake M, Hakomori SI. A specific cell surface glycoconjugate controlling cell motility: evidence by functional monoclonal antibodies that inhibit cell motility and tumor cell metastasis.Biochemistry 1991;30:3328–34.

    Article  CAS  PubMed  Google Scholar 

  20. Hilsenbeck SG, Clark GM, McGuire WL. Why do so many prognostic factors fail to pan out?Breast Cancer Res Treat 1992;22:197–206.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gwin, J.L., Klein-Szanto, A.J.P., Zhang, SY. et al. Loss of blood group antigen a in non-small cell lung cancer. Annals of Surgical Oncology 1, 423–427 (1994). https://doi.org/10.1007/BF02303816

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02303816

Key Words

Navigation